Iontophoresis is a novel technique which may be used to facilitate the movement of antibiotics into the substance of bone using an electrical potential applied externally. We have examined the rate of early infection in allografts following application of this technique in clinical practice. A total of 31 patients undergoing revision arthroplasty or surgery for limb salvage received 34 iontophoresed sequential allografts, of which 26 survived for a minimum of two years. The mean serum antibiotic levels after operation were low (gentamicin 0.37 mg/l (0.2 to 0.5); flucloxacillin 1 mg/l (0 to 1) and the levels in the drains were high (gentamicin 40 mg/l (2.5 to 131); flucloxacillin 17 mg/l (1 to 43). There were no early deep infections. Two late infections were presumed to be haemotogenous; 28 of the 34 allografts were retained. In 12 patients with pre-existing proven infection further infection has not occurred at a mean follow-up of 51 months (24 to 82).
Iontophoresis is a novel technique which may be used to facilitate the movement of antibiotics into the substance of bone using an electrical potential applied externally. We have examined the rate of early infection in allografts following application of this technique in clinical practice. A total of 31 patients undergoing revision arthroplasty or surgery for limb salvage received 34 iontophoresed sequential allografts, of which 26 survived for a minimum of two years. The mean serum antibiotic levels after operation were low (gentamicin 0.37 mg/l (0.2 to 0.5); flucloxacillin 1 mg/l (0 to 1) and the levels in the drains were high (gentamicin 40 mg/l (2.5 to 131); flucloxacillin 17 mg/l (1 to 43). There were no early deep infections. Two late infections were presumed to be haemotogenous; 28 of the 34 allografts were retained. In 12 patients with pre-existing proven infection further infection has not occurred at a mean follow-up of 51 months (24 to 82).
The successful use of structural allografts for bony defects after excision of tumours and in revision arthroplasty is well established. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] However, failure of the construct resulting from deep infection is not uncommon, with reported rates ranging between 3% and 47%. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] When established, deep infection usually necessitates removal of the allograft as part of a two-stage revision, or amputation of the limb. 1, 6, 8, 9, [27] [28] [29] [30] [31] The peri-operative introduction of the organisms or complications with the wound are the presumed modes of contamination in the majority of cases and 75% of deep infections present within the first four months after operation. 27, 32, 33 The use of long-term systemic prophylactic antibiotics to reduce the high risk of early infection is well established, 1, 32, 34, 35 although there are no published controlled clinical trials showing the efficacy of such regimes. As the allograft is avascular, antibiotics given systemically will not penetrate it.
Iontophoresis facilitates the movement of drugs, which form charged ions in solution, through tissue. This method has recently been applied to allow antibiotic supplementation of cortical allografts. 36 When applied to such material in the laboratory, levels of gentamicin of up to 187.1 mg/kg of bone and of flucloxacillin up to 31.9 mg/kg of bone were achieved in specimens of human allograft. 36 Furthermore, the slow elution of antibiotics from iontophoresed allograft bone to its surrounding milieu for periods of up to two weeks was demonstrated in vitro . The antibiotics remained biologically active and there was no thermal or structural damage to the grafts.
We have used iontophoresis to load massive cortical allografts with gentamicin and flucloxacillin in the operating theatre prior to their implantation into 31 patients, and examined the incidence of early deep post-operative infection. Because iontophoresis loads the bone itself with antibiotics, it was thought that it would help prevent deep infection of the allograft in the early post-operative period when it was most at risk.
Patients and Methods
Since June 1997 all patients who were scheduled to undergo reconstructive allograft surgery at our hospital have received iontophoresed allografts. Patients who had allergies to both flucloxacillin and gentamicin or with abnormal renal function were excluded. The operations were performed by one of two experienced surgeons (DJW and RB, who is not an author) in laminar flow theatres using exhaust hoods. All the allografts had been harvested under sterile conditions and sterilised using a minimum dose of 25 kGy of gamma irradiation prior to storage at -70˚C. Patient cohort. We loaded 45 tubular allografts from our local bone and tissue bank with antibiotics using iontophoresis and implanted them into 42 patients, three receiv- Table III ing two segmental allografts each during separate procedures. We assessed 31 patients with 34 allografts at least 24 months after operation (Tables I to III ). The remaining patients were not assessed as they had been followed up for less than 24 months. In 13 patients limb salvage was undertaken for musculoskeletal neoplasm, in 12 infection had resulted in poor bone stock and nine allografts were used in revision arthroplasty. All but one was iontophoresed using gentamicin and flucloxacillin. One patient with a penicillin allergy received an allograft iontophoresed with gentamicin only, with normal saline taking the place of the flucloxacillin solution. The allografts were used in conjunction with a wide array of implants. Antibiotic-loaded Simplex (Stryker UK Ltd., Newbury, United Kingdom) cement containing erythromycin and colistin was used in some instances. Normal peri-operative antibiotic prophylaxis was used according to the Massachusetts General Hospital protocol. 32 All patients having revision with an allograft for infection underwent a two-stage procedure with a gentamicin-loaded spacer used for a period of between six and 28 weeks, prior to implantation of the iontophoresed allograft, except for one patient in whom a second stage reimplantation was carried out 18 months after a Girdlestone excision arthroplasty. Iontophoresis. Preparation of the graft took place on a sterile trolley while the operation was taking place. An additional small non-sterile trolley was used to house the power supply for iontophoresis. The iontophoresis cell described by Day et al 36 was modified to more easily accommodate the large graft specimens and the use of the procedure in the operating theatre. Following removal from its packaging, the frozen allograft was thawed in warm sterile water. Any remaining soft tissue was removed, the canal was hand-reamed and the marrow cavity cleaned. One end of the bone was sealed with bone cement and any nutrient foraminae with bone wax. Once it was demonstrated that the construct was watertight, the allograft was stood upright in a tall polycarbonate cylinder in which was placed a circumferential stainless steel mesh sheet connected to the negative terminal of the power supply. Packs were used to hold the allograft upright and away from the sides of the container. A 1% solution of flucloxacillin sodium was poured into the cylinder around the bone and the medullary cavity was filled with a 4% solution of gentamicin sulphate. A Kirschner wire of appropriate length was placed centrally into the medullary canal and connected to the positive terminal of the power supply using a crocodile-clip lead. An electrical potential of 90 volts was applied between the electrodes and across the cortex of the bone for 20 minutes (Fig. 1) , as described by Day et al. 36 At this time the flow of current reaches a plateau, suggesting that the majority of ions have been deposited in the bone and the process is complete. The power supply was then disconnected from the electrodes. The allograft was removed from the cylinder and prepared for implantation in the usual way. At least one drain was placed alongside each allograft and the wound was closed in layers. Data collection. Samples of blood serum and of fluid from the drain alongside the graft were obtained and assayed for Table I ** case 9 in the current table is the same patient as case 10 in Table I antibiotic levels. Because a larger amount of allograft was usually iontophoresed than was needed, in 11 patients some portion of the iontophoresed allograft remained following surgery and was used for elution studies. The leftover samples were weighed and placed into polypropylene screw-top jars to which 50 ml of Ringer's saline solution (Baxter Healthcare, Toongabbie, New South Wales, Australia) was added. After 1, 2, 3, 4, 5, 7, 14 and 21 days the supernatant fluid was poured off each sample and replaced with a fresh 50 ml of Ringer's solution. The jars were kept in an incubator at 37˚C for the duration of the study. The elution fluid was assayed only for gentamicin due to the efficiency and cost effectiveness of the assay. Drain and serum fluids were assayed for both gentamicin and flucloxacillin in most cases. Gentamicin was assayed using a competitive immunoassay on an ADVIA Centaur (Bayer Healthcare, Leverkusen, Germany). Flucloxacillin was assayed using high performance liquid chromatography (Waters, Milford, Massachusetts). In a few cases a thin transverse section of leftover graft was sent for determination of bioactivity against Staphylococcus aureus . The graft was placed in the centre of a nutrient agar plate that had been flooded with a heavy suspension (10 10 organisms/L) of Staph. aureus National Collection of Type Cultures (NCTC) 6571, which had a minimum inhibitory concentration of 0.064 mg/L for gentamicin. The plates were then incubated at 35˚C overnight. A zone of inhibition of bacterial growth was used as evidence of antibacterial activity.
Clinical and radiological evaluation was undertaken before operation and at 3, 6, and 12 months after, with an annual review subsequently which is ongoing until the patient dies, or is lost to follow-up. The presence of postoperative infection of the allograft was determined on the basis of the clinical course, the results of culture, and the histology. 'Early' post-operative infections were defined as those occurring within six months of surgery, following the classification introduced by Coventry.
37

Results
Excluding the patients who have died and those whose allografts were removed for any reason, the mean duration of follow-up for the cohort as a whole was 55 months (24 to 89) (Tables I and II) .
Two-year follow-up was not available for eight allografts in seven patients due to death in five, late deep infection in one and fracture followed by late deep infection in one with two allografts. The remaining 24 patients (26 allografts) reached two years of follow-up. There were no early deep infections and all but six allografts remain in situ . A total of 11 patients died between two and 78 months after their allograft reconstruction, ten with intact functional allografts. Seven of the 11 deaths were from malignant disease, while the other four were due to medical problems unrelated to the primary indication for allograft surgery and unrelated to the use of iontophoresis. The mean age at death of the latter group was 87 years (82 to 90). The details of all deceased patients at final review have been included in the study. A total of 12 patients had preexisting proven infection. Of these, four died with uninfected functional allografts, and the remainder are free from infection at a mean follow-up of 51 months (24 to 82).
As can be expected following major allograft reconstruction there were various post-operative complications, none of which could be attributed to the iontophoresis procedure itself. No side effects were seen. There were no early infections, and late infection was seen in 7.7% (2 of 26) (95% confidence interval (CI) 0 to 24). Early complications Infection. One patient developed an infection of the wound which required debridement (Table I, case 6). Pus was seen superficially but there was no evidence of deep infection of the allograft or of the internal fixation. Streptococcus oralis was cultured from wound swabs and antibiotics were continued for 12 months as a precaution. The allograft was in situ without any signs of infection at four years. Vascular compromise. One patient with an osteosarcoma of the left pelvis and proximal femur had an internal hemipelvectomy with allograft fusion of the sacrum to the femur (Table I, case 7) . Post-operatively, vascular compromise and ischaemia developed and a hindquarter amputation was performed. The tumour spread to the stump soon afterward and the patient died of the disease within three months of the original surgery. Nonunion. One patient (Table II, The second late infection occurred in a 33-year-old male who received a hinged knee prosthesis-allograft composite after en bloc resection of the knee for chondrosarcoma of the distal femur (Table I, case 10). After 12 months the allograft was removed following fracture of the femoral stem and a new femoral component was inserted with another iontophoresed allograft (Table III, case 9). The patient presented with an acutely septic knee prosthesis 11 months after this revision. The aspirated fluid cultured Staphylococcus capitis . An arthroscopic washout and intravenous antibiotics did not control the sepsis and an above-knee amputation was performed. The histology of the allograft revealed no features suggestive of infection or osteomyelitis. In particular, the lack of any neutrophilic infiltrates within the Haversian systems of the allograft suggested that the bone was not the source of the infection, although it is impossible to rule this out completely. Fracture. There were three late fractures. One patient (Table I, case 4) sustained a fracture through an iontophoresed allograft and femoral nail, originally implanted following resection of a Ewing's sarcoma of the proximal femur 61 months previously. This was revised to a second iontophoresed proximal femoral allograft, a vascularised free fibular graft and a dynamic hip screw (Table III, case  8) . A second patient (Table III, case 5) sustained a traumatic fracture of his humeral allograft construct after falls following a stroke and was treated non-operatively. The third patient has been described previously (Table I , case 10).
Nonunion. There were three late cases of established nonunion. In one, a proximal humeral osteosarcoma was resected and reconstructed with an iontophoresed proximal femoral allograft and an expanding humeral nail (Table I,  case 12 ). Painless nonunion allowed the distal, mobile end of the nail to erode the distal humerus. The patient will undergo revision after completing a current course of chemotherapy. In the second case (Table III , case 4), persistent nonunion in a knee fusion was treated after 21 months with removal of the intramedullary fixation and the allograft, and application of an Ilizarov external ring fixator. In the third case (Table III, case 8) , delayed union at the interface of the host-femoral graft was treated at 18 months with excision of fibrous tissue and application of autogenous bone graft mixed with bone morphogenetic protein.
Ten months later the fracture had united and the patient was able to walk unaided.
Antibiotic levels
The mean levels of both antibiotics in the drain fluid at 2, 8, 12, 24 and 48 hours after operation were well above the minimum inhibitory concentration of Staph. aureus for flucloxacillin (0.5 mg/l) and gentamicin (0.5 mg/l). The serum levels remained well below the peak recommended levels for gentamicin (10 mg/l). The mean level of flucloxacillin in the drain fluid was 17 mg/l at 2 hours (1 to 43; n = 6) and 2.2 mg/l at 48 hours (1 to 6.2; n = 7). The mean serum flucloxacillin level was 1 mg/l (0 to 1) at 2 hours (n = 3) and 1 mg/l (0 to 1) at 48 hours (n = 4). The mean level of gentamicin in the drain fluid was 40 mg/l at 2 hours (2.5 to 131; n = 9) and 6 mg/l at 48 hours (1 to 14.5; n = 10). The mean serum gentamicin level was 0.37 mg/l (0.2 to 0.5; n = 7) at 2 hours and 0.34 mg/l (0.1 to 0.5; n = 5) at 48 hours (Fig. 2) .
The mean concentrations of gentamicin eluted in vitro over 21 days from 11 segments of iontophoresed allografts are illustrated in Figure 3 and demonstrate the bioavailabil- Drain and serum levels of flucloxacillin and gentamicin collected from patients post-operatively.
THE JOURNAL OF BONE AND JOINT SURGERY ity of gentamicin from the iontophoresed bone over a period of three weeks. On day 1 the mean concentration was 140 mg/kg (78 to 213). On day 21 the mean was 3.6 mg/kg (1 to 11).
The zone of inhibition of Staph. aureus surrounding a disc of iontophoresed proximal femur after 24 hours is shown in Figure 4 . It is representative of the size of the zone of inhibition created by other such samples and demonstrates that the antibiotics loaded into the bone graft by iontophoresis remain bioactive. The size of the zone of inhibition would decrease over time, as indicated by Figure 3 .
Discussion
While the use of segmental allografts has solved many problems of reconstruction in musculoskeletal surgery, infection remains a frequent and serious complication, with reported rates of up to 30% in published series of massive allografts. 5, 6, [8] [9] [10] [11] 16, 17, 20, 21, 27, [29] [30] [31] [32] [33] [34] [35] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] The susceptibility of allografts to infection is multifactorial with avascularity of the allograft, extensive soft-tissue dissection, multiple previous operations, adjuvant chemotherapy and radiotherapy all being contributing factors. [31] [32] [33] The majority of the infections of bulk allografts occur within the first six months after operation and there is strong evidence that the organisms are introduced at surgery or are related to early wound complications. Table IV lists published studies in which the rates of infection of allografts were specified, grouped by indication for surgery. Data collected by our own local bone and tissue bank over the last 12 years indicates that of 254 patients who received a segmental allograft without iontophoresis, for whom a result is known, 20 (7.9%) developed a deep infection within six months of surgery. In the limb salvage group this figure was 8.2% (4 of 49).
Many authors recommend post-operative systemic antibiotics for up to six months following major allograft surgery, although several studies have not shown reduced infection rates with this regime. 10, 32, 44 The avascularity of allografts means that systemic prophylaxis is unlikely to provide high levels of antibiotics in and near the graft. To address this problem various methods of delivering high doses of antibiotics to graft bone have been investigated. Several studies have demonstrated antibiotic release from morsellised cortical or cancellous grafts mixed with antibiotic powder 40, [54] [55] [56] [57] [58] or soaked in antibiotic solution. [59] [60] [61] [62] However, to our knowledge, no published technique other than iontophoresis has to date demonstrated high antibiotic loading of clinically useful segmental allografts in a short period of time. Although two groups have shown high release of antibiotic from solid samples of human cortical bone soaked in antibiotic solution, [60] [61] [62] in both cases the work was carried out using a small sample of approximately 1 g soaked for one or more hours. Clinically useful structural allografts, being much larger, have a much greater ratio of volume to surface area, which reduces the effectiveness of using soaking to load the bulk of the bone.
Using iontophoresis for antibiotic loading we were able to demonstrate bactericidal concentrations of antibiotic around the graft. The levels of flucloxacillin and gentamicin Photograph of a nutrient agar plate demonstrating the inhibition by a oneday-old disc of iontophoresed allograft of a heavy suspension (10 10 orgs/ L) of Staphylococcus aureus National Collection of Type Cultures 6571 which had a minimum inhibitory concentration of 0.064 mg/L for gentamicin. The large zone of inhibition clearly demonstrates the bioactivity of the iontophoresed antibiotics in the graft.
released from the allograft in the drain fluid were well above the minimum inhibitory concentrations for Staph. aureus , at least up until removal of the drain at 48 hours. Our results compare favourably with levels in the drain of only 0.6 mg/l measured after a systemic dose of 80 mg of gentamicin. 63 There were few in vivo measurements of local antibiotic levels beyond 48 hours when most of the drains were removed, but in vitro elution studies showed continued release throughout the period of testing (21 days). The serum levels of the antibiotics in all patients were well below the safe clinical limit of 10 mg/l for gentamicin, with none above 1 mg/l.
Treatment of allografts using iontophoresis provides a unique method of prophylaxis since the antibiotics are present within the graft itself rather than just in the space around it. The technique results in an antibiotic gradient outward from the graft, in contrast to that created by systemic prophylaxis, antibiotic bone cement or beads. Furthermore, it provides a local depot of antibiotics for uncemented allografts which would otherwise be absent. The constant elution of antibiotics from the graft in the early post-operative period should prevent bacterial colonisation of its surface, with the gentamicin and flucloxacillin providing a synergistic mechanism for killing any contaminants. One concern is that high levels of antibiotics local to the graft may interfere with bone healing and incorporation of the graft, but work with small-volume grafts has shown otherwise. 40, 54, 57 The current series has a rate of nonunion of 11.8% (4 of 34), which is comparable with recent published rates of nonunion in untreated allografts of between 4% and 44%. 15, 18, 19, 22, 31, 50, [64] [65] [66] [67] [68] No early deep allograft infections requiring removal of the graft were seen in the present series. One early wound infection which required debridement did not involve or require removal of the allograft and did not progress to an early infection. The most serious complications seen in the present series were two late deep infections, both of which necessitated the removal of the allograft. Both cases were infected with commensal organisms and presented acutely on previously satisfactory constructs. S. mitis was cultured from one infected allograft 15 months following implantation. It is not a common pathogen encountered in allograft infection and most likely seeded haematogenously from its normal habitat of the respiratory tract. Staph. capitis , another commensal, was cultured from the joint fluid in a knee replacement of the other patient. Both deep infections occurred more than 11 months after implantation in patients who had previously sustained peri-prosthetic frac- tures. Based on our in vitro studies, this is well beyond the effective duration of iontophoresed antibiotics. This investigation into the clinical application of iontophoresis has several limitations. The small numbers of patients requiring bulk allograft surgery means that collection of data is slow and the numbers of patients are currently inadequate to achieve statistical significance. Nevertheless, the early results are promising and more patients are being recruited to improve the statistical power.
